The GeneXpert MTB/RIF Ultra is a rapid molecular diagnostic test designed to detect Mycobacterium tuberculosis (MTB) and resistance to rifampicin, a key first-line drug for tuberculosis treatment. Using advanced cartridge-based technology, it provides highly sensitive results within hours, making it especially valuable for early diagnosis and management of TB, including drug-resistant cases. Its purpose is to enable timely treatment decisions and improve patient outcomes.
Unlike culture methods that take weeks, GeneXpert MTB/RIF Ultra delivers quick, accurate results, even in cases with low bacterial load, improving early detection and patient care.
Certainly, it can analyze non-sputum samples like pus, tissue, or body fluids, making it useful for diagnosing TB outside the lungs when clinically indicated.
The test helps identify TB quickly and determines drug resistance, enabling timely treatment decisions, reducing transmission risk, and improving patient outcomes, especially in drug-resistant cases.
Yes, it specifically identifies resistance to rifampicin, a key first-line TB drug, which serves as a strong indicator of multidrug-resistant tuberculosis requiring specialized treatment.
The test specifically detects rifampicin resistance, a key marker of multidrug-resistant TB, helping clinicians decide on appropriate treatment regimens quickly and effectively.
It is highly sensitive and specific, endorsed by WHO for TB diagnosis, especially in high-burden settings, ensuring dependable results for both pulmonary and extrapulmonary TB cases.
...
Didn't recieved OTP Yet? Resend OTP